Company
United StatesPublic company, NYSE: CLColgate Palmolive Company (NYSE: CL), Cambridge, OH – FDA Inspections
Inspection records and compliance data for Colgate Palmolive Company in Cambridge, Ohio. 2 FDA inspections on record, last inspected April 05, 2011. Publicly traded as NYSE: CL.
Company Profile
This profile covers Colgate Palmolive Company based in Cambridge, Ohio, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected February 11, 2009. Last inspected April 5, 2011.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| April 5, 2011 | NAI | Human Drugs · Drug Quality Assurance | 718199 |
| February 11, 2009 | NAI | Human Drugs · Drug Quality Assurance | 559705 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Colgate Palmolive Company
Stock ticker
CL
Exchange
NYSE
Share price
$98.71
Market cap
$78.5B
Price as of
November 6, 2026
FEI Number
1000305988
Address
8800 Guernsey Industrial Blvd, Cambridge, Ohio 43725, United States
Country
United States
ID: 52b37aa7-6f21-4210-aa7b-442ca6552d91